Insomnia

Current Treatment Options in Neurology

Volumn 7, Issue 5, 2005, Pages 373-386

  Yang, Chien Ming ^a   Speilman, Arthur J ^b   Huang, Yu Shu ^b  

^a NATIONAL CHENGCHI UNIVERSITY   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CIMETIDINE; CLONIDINE; DIPHENHYDRAMINE; ESTAZOLAM; FLURAZEPAM; HYPNOTIC AGENT; KETOCONAZOLE; MELATONIN; MIRTAZAPINE; NEFAZODONE; ORAL CONTRACEPTIVE AGENT; PHENYTOIN; PROPRANOLOL; QUAZEPAM; RIFAMPICIN; TEMAZEPAM; TRAZODONE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ABDOMINAL DISCOMFORT; ANTEROGRADE AMNESIA; ANXIETY DISORDER; AROUSAL; ATAXIA; BEHAVIOR THERAPY; BITTER TASTE; BODY WEIGHT DISORDER; CHRONOTHERAPY; CIRCADIAN RHYTHM; COGNITIVE DEFECT; COGNITIVE THERAPY; CONFUSION; CONSTIPATION; DIET THERAPY; DISEASE ASSOCIATION; DIZZINESS; DROWSINESS; DRUG DEPENDENCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERANCE; DYSURIA; EJACULATION DISORDER; ERECTILE DYSFUNCTION; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ARRHYTHMIA; HOMEOSTASIS; HUMAN; INSOMNIA; LIFESTYLE; LIVER FAILURE; LONG TERM CARE; MEMORY DISORDER; MUSCLE WEAKNESS; ORTHOSTATIC HYPOTENSION; PATHOGENESIS; PATIENT EDUCATION; PHOTOTHERAPY; PRIAPISM; QT PROLONGATION; RELAXATION TRAINING; RESPIRATION DEPRESSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEDATION; SHORT COURSE THERAPY; SOMNOLENCE; TORSADE DES POINTES; URINE RETENTION; VISUAL IMPAIRMENT; WEIGHT GAIN; WITHDRAWAL SYNDROME; XEROSTOMIA;

EID: 29744464302     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-005-0030-2     Document Type: Review

References (66)

1. Ohayan MM, Caulet M, Priest RG, Guilleminault C: DSM-PV and ICSD-90 insomnia symptoms and sleep dissatisfaction. Br J Psychiatry 1997, 171:382-388.
2. Mellinger GD, Balter MB, Uhlenhuth EH: Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry 1985, 42:225-232.
3. Sateia MJ, Doghramji K, Hauri PJ, Morin CM: Evaluation of chronic insomnia: an American Academy of Sleep Medicine review. Sleep 2000, 23:243-308.
4. World Health Organization (WHO): The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
5. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: The American Psychiatric Association; 2000.
6. Breslau N, Roth T, Rosenthal L, Andreski P: Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 1996, 39:411-418.
7. Ford D, Kamerow D: Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA 1989, 262:1479-1484.
8. Katz DA, McHorney CA: Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 1998, 158:1099-1107.
9. Klink M, Quan S, Kaltenborn W, Lobowitz M: Risk factors associated with complaints of insomnia in a general adult population. Arch Intern Med 1992, 152:1634-1637.
10. Gislason T, Reyrnisdotter H, Kritbjarnarson H, Benediktsdotter B: Steep habits and sleep disturbances among the elderly: an epidemiological survey. J Intern Med 1993, 234:31-39.
11. Janson C, Lindberg E, Gislason T, et al.: Insomnia in men: a 10-year prospective population based study. Sleep 2001, 24:425-430.
12. Ohayon MM: Relationship between chronic painful condition and insomnia. J Psychiatr Res 2005, 39:151-159.
13. Borbely AA: A two process model of sleep regulation. Hum Neurobiol 1982, 1:195-204.
14. Bonnet MH, Arand DL: Hyperarousal and insomnia. Sleep Med Rev 1997, 2:97-108.
15. Perlis ML, Giles DE, Mendelson WB, et al.: Psychophysiological insomnia: the behavioral model and a neurocognitive perspective. J Sleep Res 1997, 6:179-188.
16. Bonnet MH, Arand DL: 24-hour metabolic rate in insomniacs and matched normal sleepers. Sleep 1995, 18:581-588.
17. Vgontzas AN, Tsigos C, Bixler EO, et al.: Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res 1998, 45:21-31.
18. Freedman RR: EEG power spectra in sleep-onset insomnia. Electroencephalogr Clin Neurophysiol 1986, 63:408-413.
19. Merica H, Blois R, Gaillard J-M: Spectral characteristics of sleep EEG in chronic insomnia. Eur J Neurosci 1998, 10:1826-1834.
20. Perlis ML, Smith MT, Andrews PJ, et al.: Beta/gamma EEG activity in patients with primary and secondary insomnia and good sleeper controls. Sleep 2001, 24:110-117.
21. Bootzin RR: Stimulus control treatment for insomnia. Proc Am Psychol Assoc 1972, 7:395-396.
22. Weitzman ED, Czeisler CA, Coleman RM, et al.: Delayed sleep phase syndrome: a chronobiological disorder with sleep-onset insomnia. Arch Gen PsyChiatry 1981, 38:737-746.
23. Thorpy MJ, Korman E, Spielman AJ, Glovinsky PB: Delayed sleep phase syndrome in adolescents. J Adolesc Health Care 1988, 9:22-27.
24. Czeisler CA, Dumont M, Duffy JF, et al.: Association of sleep-wake habits in older people with changes in output of circadian pacemaker. Lancet 1992, 340:933-936.
25. Kramer CJ, Kerkhof GA, Hofman WF: Age differences in sleep-wake behavior under natural conditions. Pers Individ Dif 1999, 27:853-860.
26. Spielman AJ: Assessment of insomnia. Clin Psychol Rev 1986, 6:11-25.
27. Mendelson WB, Roth T, Cassella J, et al.: The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 new clinical drug evaluation unit meeting symposium. Sleep Med Rev 2004, 8:7-17.
28. Morin CM, Hauri PJ, Espie CA, et al.: Nonpharmacologic treatment of chronic insomnia. Sleep 1999, 22:1-23.
29. Murtagh DRR, Greenwood KM: Identifying effective psychological treatment for insomnia: a meta-analysis. J Consult Clin Psychol 1995, 63:79-89.
30. Morin CM, Colecchi C, Stone J, et al.: Behavioral and pharmacological therapies for late-life insomnia. JAMA 1999, 281:991-999.
31. Jacobs GD, Pace-Schott EF, Stickgold R, et al.: Cognitive behavior therapy and pharmacotherapy for insomnia. Arch Intern Med 2004, 164:1888-1896.
32. Edinger JD, Sampson WS: A primary care "friendly" cognitive behavioral insomnia therapy. Sleep 2003, 26:177-182.
33. Spielman AJ, Saskin P, Thorpy MJ: Treatment of chronic insomnia by restriction of time in bed. Sleep 1987, 10:45-56.
34. Friedman L, Bliwise DL, Yesavage JA, et al.: A preliminary study comparing sleep restriction and relaxation treatments for insomnia in older adults. J Gerontol B Psychol Sci 1991, 46:1-8.
35. Rubenstein ML, Rothenberg SA, Maheswaran S, et al.: Modified sleep restriction therapy in middle-aged and elderly chronic insomniacs [abstract]. Sleep Res 1990, 19:276.
36. Borkovec TD, Grayson JB, O'Brien GT, et al.: Relaxation treatment of pseudoinsomnia and idiopathic insomnia: an electroencephalographic evaluation. J Appl Behav Anal 1979, 12:37-54.
37. Nicassio P, Bootzin R: A comparison of progressive relaxation and autogenic training as treatment for insomnia. J Abnorm Psychol 1974, 83:253-260.
38. Woolfolk RL, Carr-Kaffashan L, McNulty TF: Meditation training as a treatment for insomnia. Behav Ther 1976, 7:359-365.
39. Haynes SN, Sides H, Lockwood G: Relaxation instructions and frontalis electromyographic feedback intervention with sleep-onset insomnia. Behav Ther 1977, 8:644-652.
40. Hauri PJ: Treating psychophysiologic insomnia with biofeedback. Arch Gen Psychiatry 1981, 38:752-758.
41. Morin CM, Stone J, Trinkle D, et al.: Dysfunctional beliefs and attitudes about sleep among older adults with and without insomnia complaints. Psychol Aging 1993, 8:463-467.
42. Morin CM: Insomnia: Psychological Assessment and Management. New York: Guilford; 1993.
43. Czeisler CA, Allan JS, Strogatz SH, et al.: Bright light resets the human circadian pacemaker independent of the timing of the sleep-wake cycle. Science 1986, 233:667-671.
44. Minors DS, Waterhouse JM, Wirz-Justice A: A human phase-response curve to light. Neurosci Lett 1991, 133:354-361.
45. Chesson Jr AL, Littner M, Davila D, et al.: Practice parameters for the use of light therapy in the treatment of sleep disorders. Standards of Practice Committee, American Academy of Sleep Medicine. Sleep 1999, 22:641-660.
46. Campbell SS, Dawson D, Anderson MW: Alleviation of sleep maintenance insomnia with timed exposure to bright light. J Am Geriatr Soc 1993, 41:829-836.
47. Aschoff J, Wever R: Human circadian rhythms: a multioscillatory system. Fed Proc 1976, 35:236-332.
48. Czeisler CA, Richardson GS, Coleman RM, et al.: Chronotherapy: resetting the circadian clocks of patients with delayed sleep phase insomnia. Sleep 1981, 4:1-21.
49. Walsh JK: Pharmacologic management of insomnia. J Clin Psychiatry 2004, 65(Suppl 16):41-45.
50. Ringdahl EN, Pereira SL, Delzell Jr JE: Treatment of primary insomnia. J Am Board Fam Pract 2004, 17:212-219.
51. Krystal AD: The changing perspective on chronic insomnia management. J Clin Psychiatry 2004, 65:20-25.
52. Zhdanova IV: Advances in the management of insomnia. Exp Opin Pharmacother 2004, 5:1573-1579.
53. Dundar Y, Dodd S, Strobl J, et al.: Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol 2004, 19:305-322.
54. Holm KJ, Goa KL: Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs 2000, 59:865-889.
55. Perlis ML, McCall WV, Krystal AD, et al.: Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatry 2004, 65:1128-1137.
56. Cluydts R: Zolpidem 'as needed': methodological issues and clinical findings. CNS Drugs 2004, 18(Suppl 1):25-33.
57. Dooley M, Plosker GL: Zaleplon: a review of its use in the treatment of insomnia. Drugs 2000, 60:413-445.
58. Israel AG, Kramer JA: Safety of zaleplon in the treatment of insomnia. Annals of Pharmacotherapy 2002, 36:852-859.
59. Hajak G: A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience. Drug Safety 1999, 21:457-469.
60. Chouinard G: Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry 2004, 65(Suppl 5):7-12.
61. Thase ME: Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry 1999, 60(Suppl 17):28-31.
62. James SP, Mendelson WB: The use of trazodone as a hypnotic: a critical review. J Clin Psychiatry 2004, 65:752-755.
63. Stone BM, Turner C, Mills SL, Nicholson AN: Hypnotic activity of melatonin. Sleep 2000, 23:663-669.
64. Lewy AJ, Ahmed S, Jackson JL, Sack RL: Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int 9:380-92.
65. Mindell JA: Empirically supported treatments in pediatric psychology: bedtime refusal and night wakings in young children. J Pediatr Psychol 1999, 24:465-481.
66. Younus M, Labellarte MJ: Insomnia in children: when are hypnotics indicated? Paediatr Drugs 2002, 4:391-403.